SeaBeLife receives close to €1.4M deep tech financing from Bpifrance
Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
Tollys and Gustave Roussy enter into new research agreement
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
Yposkesi, an SK pharmteco company, appoints US-based executive director for business development
Abzena, Alira Health and Oncodesign launch DRIVE-Biologics to support access to specialist services from discovery to clinical development for oncology and inflammation
Biomunex and Institut Curie pursue strategic collaboration for development of disruptive non-conventional T cell redirection approach to treating cancer
Human Cell Design launches Endoc-BH5, an advanced human beta cell model enabling new discoveries in type 1 and 2 diabetes research
Tollys accelerates development of TLR3 agonist candidates for intravenous administration in immuno-oncology
Tollys accelerates development of TLR3 agonist candidates for intravenous administration in immuno-oncology